Psychiatry and Neurology, Neurology · Grand Rapids, MI
NPI
1134357015
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
275 Michigan St NE
Grand Rapids, MI, 49503
Phone (616) 267-7401
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
686 services
Medicare patients, 2024
240
Average age 74
Drug cost, 2024
$867K
3,477 prescriptions
Company payments, 2025
$727
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert R Coleman was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 121 times for 114 patients. In total Robert R Coleman billed 686 services in 26 codes, and Medicare paid $40K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 121 | 114 | $13.09 | $1,584 |
| 99215 Office E&M - Established | Office | 93 | 76 | $106.61 | $9,915 |
| 99214 Office E&M - Established | Office | 91 | 82 | $70.88 | $6,450 |
| 95874 Musculoskeletal | Office | 67 | 27 | $13.06 | $875 |
| 64616 Musculoskeletal | Office | 50 | 20 | $108.37 | $5,418 |
| 99213 Office E&M - Established | Office | 48 | 45 | $49.71 | $2,386 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 19 | 14 | $26.04 | $495 |
| 99204 Office E&M - New | Office | 13 | 13 | $119.44 | $1,553 |
| 99205 Office E&M - New | Office | 11 | 11 | $121.57 | $1,337 |
By year: 2022 $176K for 20,904 services; 2023 $151K for 20,712 services; 2024 $40K for 686 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert R Coleman prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,005 prescriptions and refills. In total Robert R Coleman wrote 3,477 Medicare prescriptions that cost $867K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,005 | 2,382 | 341 | $74K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 289 | 708 | 101 | $21K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 165 | 380 | 65 | $6,512 |
| Gabapentin Generic | 163 | 301 | 58 | $2,768 |
| Donepezil Hcl Generic | 155 | 322 | 50 | $2,515 |
| Escitalopram Oxalate Generic | 125 | 286 | 35 | $2,289 |
| Clonazepam Generic | 107 | 171 | 29 | $1,267 |
| Propranolol Hcl Er Propranolol Hcl | 102 | 225 | 30 | $5,955 |
| Primidone Generic | 100 | 274 | 36 | $4,953 |
| Rytary Carbidopa/Levodopa | 87 | 161 | 21 | $142K |
| Quetiapine Fumarate Generic | 79 | 156 | 19 | $752 |
| Mirtazapine Generic | 72 | 143 | 24 | $1,428 |
| Ropinirole Hcl Generic | 72 | 150 | 16 | $2,159 |
| Amantadine Amantadine Hcl | 71 | 155 | 25 | $3,193 |
| Topiramate Generic | 56 | 141 | 25 | $1,563 |
Brand drugs: 247 claims; generic drugs: 3,230 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert R Coleman $727 ($727 in general payments such as food, travel and fees) from 13 companies. The largest payer was UCB, Inc. with $208.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 13 | $208 |
| Abbvie Inc. ABBV | 7 | $189 |
| Boston Scientific Corporation BSX | 1 | $63.79 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $47.97 |
| Neurelis, Inc. | 2 | $38.49 |
| Aucta Pharmaceuticals, Inc. | 4 | $37.26 |
| Upsher-Smith Laboratories LLC | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $27.79 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $26.16 |
| Medtronic, Inc. MDT | 1 | $22.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.